Siemens Healthineers to Invest EUR 350 Million in New Campus Forchheim

Siemens HealthineersSiemens Healthineers is planning to expand its location in Forchheim in response to the continuing strong demand for medical imaging devices, in particular for CT scanners and x-ray applications. The new "Siemens Healthineers Campus" will consist of an ultra-modern factory for medical components and a new R&D and logistics center alongside the existing facilities. Siemens Healthineers will be investing around EUR 350 million in this project over the next five years. Construction at the site is scheduled to begin in 2020.

"With its IPO, Siemens Healthineers set itself the clear ambition to shape the future of healthcare. This forward-looking investment into the Forchheim campus is a critical milestone paying into this direction. It reinforces our claim to generate sustainable, profitable growth based on the strength of our market and technology leadership as well as demonstrating our commitment to our home market Germany," said Michael Sen, Supervisory Board Chairman of Siemens Healthineers.

"This is one of the biggest investments ever made by Siemens Healthineers. Construction of this ultra-modern campus in Forchheim demonstrates our commitment to meeting the strong demand for imaging technology and will help us secure our position as an innovation and market leader," stated Bernd Montag, CEO of Siemens Healthineers.

Production of x-ray tube assemblies and generators for x-ray machines is planned to begin in 2023. The new facilities will consist of 47,000 square meters, and the existing production for these components in Erlangen, with around 700 employees, will be relocated to Forchheim. The new state-of-the-art facility will make production less costly, enhance the quality of the products and provide adequate capacities for further growth.

The company currently has separate facilities for x-ray machines and generators in the neighboring city of Erlangen. Expansion of the production capacities at the existing locations is not possible due to a lack of space. Siemens Healthineers is therefore also expanding its Forchheim location by purchasing more land. The Forchheim city council already approved the preliminary planning application in October 2018. Buildings being vacated in Erlangen will be used for other purposes by Siemens Healthineers and Siemens AG in the future.

In addition to the production and administration buildings at the site, Siemens Healthineers plans to construct a test and development center at the Forchheim Campus. Construction of a car park for employees on the site is also planned. The pace of innovation and development and exploitation of synergy potential are to be accelerated and enhanced through the close interaction of the two production facilities and direct proximity to the business units. For example, CT scanners are to be built in Forchheim, thus shortening the supply channels for the x-ray tube assemblies and generators used in these products to a minimum in the future. Having the business units in the immediate vicinity will also improve coordination in the development and production of the equipment.

The headquarters of both the Diagnostic Imaging (DI) and Advanced Therapy (AT) business segments are currently located in Forchheim. The future Campus will consist of the existing production and administration buildings, along with the new development and production facilities for x-ray tube assemblies and generators.

X-ray tube assemblies and x-ray generators are medical components used in CT scanners, for example. The x-ray tube assemblies contain the x-ray tubes that generate the x-ray radiation. X-ray generators include all the components required for operation of the x-ray tubes. They also generate and regulate the high voltage required for operation of the x-ray tubes.

About Siemens Healthineers

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...